Guangzhou Regenerative Medicine and Health Guangdong Laboratory (GRMH-GDL)
Guangzhou Regenerative Medicine and Health Guangdong Laboratory (GRMH-GDL)
Publications
Home >> Research >> Outputs >> Publications
Y08197 is a novel and selective CBP/EP300 bromodomain inhibitor for the treatment of prostate cancer

Article

Y08197 is a novel and selective CBP/EP300 bromodomain inhibitor for the treatment of prostate cancer

Journal

Acta Pharmacologica Sinica

First Author

Ling-jiao Zou;Qiu-ping Xiang;Xiao-qian Xue

Corresponding Author

Yong Xu

IF

3.562

GDL Member

Yong Xu

Released Time

2019, 5